Detection of urinary arimistane metabolites in humans using liquid chromatography-mass spectrometry: Complementary results to gas chromatography mass spectrometric data and its application to antidoping analyses.

Détails

ID Serval
serval:BIB_9394BAB0B049
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Detection of urinary arimistane metabolites in humans using liquid chromatography-mass spectrometry: Complementary results to gas chromatography mass spectrometric data and its application to antidoping analyses.
Périodique
Rapid communications in mass spectrometry
Auteur⸱e⸱s
Martinez Brito D., Leogrande P., Botrè F., de la Torre X.
ISSN
1097-0231 (Electronic)
ISSN-L
0951-4198
Statut éditorial
Publié
Date de publication
30/06/2021
Peer-reviewed
Oui
Volume
35
Numéro
12
Pages
e9080
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The metabolism of arimistane (Arim) was first described in 2015, and androst-3,5-diene-7β-ol-17-one was proposed as the main metabolite excreted in urine. Recently, a more detailed study describing the findings in urine after the administration of Arim has been published. This study corroborated the previously described metabolite but also described several phase I and II metabolites, analyzing trimethylsilylated urinary extracts using accurate mass spectrometry coupled to gas chromatography (GC/qTOF). The present communication is an extension of this late investigation aiming to implement the results of Arim metabolism using either accurate mass spectrometry and/or triple quadrupole tandem mass spectrometry, both coupled to liquid chromatography (LC/qTOF and LC/QqQ).
The samples used in this study were the same as previously studied using GC/qTOF. One single oral dose of Arim was administered to three volunteers, and samples collected before and up to 10 h after the Arim administration were analyzed. The unconjugated fraction of urine was removed, and the hydrolysis was performed with β-glucuronidase from Escherichia coli. The extracts were reconstituted in water:acetonitrile before the LC/qTOF and LC/QqQ analysis.
The presence of the proposed metabolites studied using GC was verified by accurate mass measurements. Twelve metabolites not found in the blank urine samples were identified by the accurate mass spectra with acceptable errors between -7.5 and 8.1 ppm: 4 reduced metabolites, 4 monohydroxylated metabolites, and 4 with an additional hydroxylation (bis-hydroxylated metabolites). Unlike in the study carried out using GC/qTOF, Arim itself was found in the samples of the three volunteers.
Twelve metabolites were identified, and specific transitions were proposed. Despite the good results, some limitations remain. As for GC/qTOF, the α- or β configuration of hydroxy groups, as well as the exact position for some unsaturation, cannot be assigned with certainty. Because certified reference materials of these metabolites are not yet available, the molecular structures were hypothesized considering the previous study using GC.
Mots-clé
Chromatography, High Pressure Liquid/methods, Doping in Sports/methods, Gas Chromatography-Mass Spectrometry/methods, Humans, Molecular Structure, Performance-Enhancing Substances/chemistry, Performance-Enhancing Substances/urine, Pharmaceutical Preparations/urine, Urine/chemistry
Pubmed
Web of science
Création de la notice
27/03/2021 17:02
Dernière modification de la notice
05/05/2023 6:57
Données d'usage